tenk.fyi

MBX Biosciences, Inc.

MBXNasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$87.0M

40.5% YoY

EPS

$-2.38

59.1% YoY

Cash

$75.3M

52.6% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro